A2M the a2 milk company limited

1.67%

$7.93

Chart Update, page-23086

First 23086 Last

Share
Profile

Follow
minimoke

2,946 Posts.

436

24/05/22

09:15

Post #: 61580818
Share

Originally posted by werdplaya58: ↑

Thanks, haven't got a response to mine yet but i expect this is the stock standard cut and paste one they've spent the past week coming up with.

Can't say I am surprised and this is what I warned everyone to expect. Those assuming that the company would do something/anything at all to benefit from the situation would be dissapointed. They appear to lack a great deal of adaptability.

Talking about WIC and regulatory approvals completely misses the point and looks to be from their standard response on this question BEFORE the shortages and temporary relaxation of import restrictions. To send formula now, in the current window, it doesn't need to be manufactured in the USA. And the WIC program is clearly falling short at the moment.

Very disappointing response IMO.

Expand

I'm neither surprised or disappointed. Synlait and Munchkin couldn't get into the USA. So why would A2 and Synlait?

What I am happy about is the distraction I am hoping is being created in other IMF manufacturers / distributors.

I am hopeful they are taking their eyes off their key markets (leaving opportunities for A2M with achievable ambitions) while the chase the US "opportunity".

A2M Price at posting: $4.43 Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

AII

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

First 23086 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $7.93		Change 0.130(1.67%)		Mkt cap ! $5.741B

Open	High	Low	Value	Volume
$7.87	$7.99	$7.71	$17.74M	2.261M

Buyers (Bids)

No.	Vol.	Price($)
4	111	$7.93

Sellers (Offers)

Price($)	Vol.	No.
$7.96	3799	2

View Market Depth

No.	Vol.	Price($)
1	400	7.710
4	5739	7.700
1	64	7.680
3	2750	7.670
1	500	7.660

Price($)	Vol.	No.
7.960	565	1
7.990	8000	1
8.000	6318	7
8.010	6039	2
8.020	3294	2

Last trade - 16.13pm 27/06/2025 (20 minute delay)

A2M (ASX) Chart

Chart Update, page-23086

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Australia’s gas crisis is here – and dying coal plants aren’t helping

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Monash IVF shares cater 25% – Disaster or deep-value play?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Chart Update, page-23086

Top Stories

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Australia’s gas crisis is here – and dying coal plants aren’t helping

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Monash IVF shares cater 25% – Disaster or deep-value play?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News